Clinicians Push Earlier JAK Inhibitor Use in AD and Vitiligo
Fall Clinical Derm 2026 experts say JAK inhibitors should move earlier in AD and vitiligo care, before disease becomes chronic and pigment reserves are lost.
Topic
Topic
Fall Clinical Derm 2026 experts say JAK inhibitors should move earlier in AD and vitiligo care, before disease becomes chronic and pigment reserves are lost.
A new global consensus on integrated skin care sets out shared principles for sequencing medical, device and aesthetic therapies…
New Dermatology Times guidance examines how to order hedgehog inhibitors with surgery, radiation and immunotherapy in advanced ba…